Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Thea Pharma
Lexington, Massachusetts, United Statestheapharmainc.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Thea Pharma, as the US and Irish subsidiary of Laboratoires Théa, commercializes a broad portfolio of preservative-free ophthalmic products for anterior segment and ocular surface conditions, with several products considered standard of care in Europe and growing uptake in the US[1][2][3][4][5].
- Therapeutic areas
- ImmunologyInfectious DiseasesOphthalmology
- Modalities
- Small moleculeDeviceBiologic
- Industry
- Biotech
02
Partnerships
US and Irish healthcare providersOphthalmology clinicsEuropean pharma partnerships via Laboratoires Théa
Beyond the preview
Go deeper on Thea Pharma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Thea Pharma.